Pharmaron Beijing Co Ltd (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Pharmaron Beijing Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2023 | 0.4949 |
| December 31, 2022 | 0.5077 |
| September 30, 2022 | 0.4883 |
| June 30, 2022 | 0.4748 |
| March 31, 2022 | 0.488 |
| December 31, 2021 | 0.4937 |
| September 30, 2021 | 0.504 |
| June 30, 2021 | 0.511 |
| March 31, 2021 | 0.1332 |
| December 31, 2020 | 0.0975 |
| September 30, 2020 | 0.0477 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.0282 |
| March 31, 2020 | 0.0231 |
| December 31, 2019 | 0.1168 |
| September 30, 2019 | 0.4988 |
| June 30, 2019 | 0.4856 |
| March 31, 2019 | 0.5475 |
| December 31, 2018 | 0.636 |
| September 30, 2018 | 0.661 |
| June 30, 2018 | 0.702 |
| March 31, 2018 | |
| December 31, 2017 | 0.6514 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0231
Minimum
Mar 2020
0.511
Maximum
Jun 2021
0.3149
Average
0.4814
Median
Debt to Equity Ratio Benchmarks
| Sino Biopharmaceutical Ltd | 0.2896 |
| HUTCHMED (China) Ltd | 0.1109 |
| Regencell Bioscience Holdings Ltd | -- |
| Prenetics Global Ltd | 0.00 |
| Uni-Bio Science Group Ltd | 0.2638 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.058B |
| Total Liabilities (Quarterly) | 1.420B |
| Shareholders Equity (Quarterly) | 1.595B |